Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Giraud

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
The American Journal of Cardiology|July 12, 2020
Radiotherapy in Patients With a Cardiac Implantable Electronic DeviceArdalan Sharifzadehgan, Marc Laurans, Marine Thuillot, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2017
Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted AnalysisJean-Emmanuel Bibault, Sophie Dussart, Pascal Pommier, et al.
Frontiers in Oncology|January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective StudyIngrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.
Bulletin Du Cancer|November 1, 2006
[The cost of intensity modulated radiation therapy in head and neck cancers: results of the 2002 STIC study]M Julia Bonastre, Eric Noël, René-Jean Bensadoun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2012
Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02)Juliette Thariat, René-Jean Bensadoun, Marie-Christine Etienne-Grimaldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted pictureJuliette Thariat, Marie-Christine Etienne-Grimaldi, Dominique Grall, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2024
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus InitiativeClémence Basse, Jonathan Khalifa, François Thillays, et al.
The Lancet. Oncology|August 12, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [<sup>18</sup>F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trialPierre Vera, Sébastien Thureau, Florence Le Tinier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2025
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung CancerPierre Vera, Philippe Giraud, Sébastien Hapdey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2013
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]B Chauvet, M-A Mahé, P Maingon, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The American Journal of Cardiology|July 12, 2020
Radiotherapy in Patients With a Cardiac Implantable Electronic DeviceArdalan Sharifzadehgan, Marc Laurans, Marine Thuillot, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2017
Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted AnalysisJean-Emmanuel Bibault, Sophie Dussart, Pascal Pommier, et al.
Frontiers in Oncology|January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective StudyIngrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.
Bulletin Du Cancer|November 1, 2006
[The cost of intensity modulated radiation therapy in head and neck cancers: results of the 2002 STIC study]M Julia Bonastre, Eric Noël, René-Jean Bensadoun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2012
Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02)Juliette Thariat, René-Jean Bensadoun, Marie-Christine Etienne-Grimaldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted pictureJuliette Thariat, Marie-Christine Etienne-Grimaldi, Dominique Grall, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2024
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus InitiativeClémence Basse, Jonathan Khalifa, François Thillays, et al.
The Lancet. Oncology|August 12, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [<sup>18</sup>F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trialPierre Vera, Sébastien Thureau, Florence Le Tinier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2025
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung CancerPierre Vera, Philippe Giraud, Sébastien Hapdey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2013
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]B Chauvet, M-A Mahé, P Maingon, et al.
Pageof 10